ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Order Full text via Infotrieve
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jones, K.
Right arrow Articles by Davies, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jones, K.
Right arrow Articles by Davies, B.
Eur Respir J 1990; 3: 152-156
Copyright © ERS Journals Ltd 1990


Original Articles

A comparison of albumin and urea as reference markers in bronchoalveolar lavage fluid from patients with interstitial lung disease

KP Jones, JH Edwards, SP Reynolds, TJ Peters, and BH Davies

Lavage fluids were investigated for 67 subjects in 6 groups: 12 with active sarcoidosis, 8 with inactive sarcoidosis, 17 with pigeon breeder's disease, 10 asymptomatic pigeon breeders, 12 with idiopathic pulmonary fibrosis (IPF) and 8 normal subjects. Albumin and urea per ml of bronchoalveolar lavage fluid (BALF) were determined for each subject together with percentage return of fluid (BAL%). Novel assay systems were employed to measure urea and albumin and these were compared with existing analytical techniques. When compared with the control group, we found that urea per ml of BALF was not statistically different for all other groups, except those with pigeon breeder's disease who had significantly raised levels. For albumin, however, three groups had significantly higher levels than the controls, namely those with active sarcoidosis, pigeon breeder's disease and IPF. BAL% return showed no significant differences for any group when compared with the controls. We conclude that since albumin is significantly raised in most patients with interstitial lung disease it does not represent a suitable marker for the quantitation of reactive proteins in BALF. Urea shows much less variability between groups than does albumin, and hence in the absence of a proven alternative represents the most reliable estimate available of epithelial lining fluid dilution during the lavage procedure, providing dwell time is kept to a minimum.


This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
A. S. Jackson, A. Sandrini, C. Campbell, S. Chow, P. S. Thomas, and D. H. Yates
Comparison of Biomarkers in Exhaled Breath Condensate and Bronchoalveolar Lavage
Am. J. Respir. Crit. Care Med., February 1, 2007; 175(3): 222 - 227.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
R. Montes-Vizuet, A. Vega-Miranda, E. Valencia-Maqueda, M. C. Negrete-Garcia, J. R. Velasquez, and L. M. Teran
CC chemokine ligand 1 is released into the airways of atopic asthmatics
Eur. Respir. J., July 1, 2006; 28(1): 59 - 67.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. Hirsch, K. C. Hansen, A. L. Burlingame, and M. A. Matthay
Proteomics: current techniques and potential applications to lung disease
Am J Physiol Lung Cell Mol Physiol, July 1, 2004; 287(1): L1 - L23.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
C. Hermans, M. Petrek, V. Kolek, B. Weynand, T. Pieters, M. Lambert, and A. Bernard
Serum Clara cell protein (CC16), a marker of the integrity of the air-blood barrier in sarcoidosis
Eur. Respir. J., September 1, 2001; 18(3): 507 - 514.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
C. M. LILLY, H. NAKAMURA, O. I. BELOSTOTSKY, K. J. HALEY, E. A. GARCIA-ZEPEDA, A. D. LUSTER, and E. ISRAEL
Eotaxin Expression after Segmental Allergen Challenge in Subjects with Atopic Asthma
Am. J. Respir. Crit. Care Med., June 1, 2001; 163(7): 1669 - 1675.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child. Fetal Neonatal Ed.Home page
J. R McColm, B. J Stenson, N. Biermasz, and N. McIntosh
Measurement of interleukin 10 in bronchoalveolar lavage from preterm ventilated infants
Arch. Dis. Child. Fetal Neonatal Ed., March 1, 2000; 82(2): 156F - 159.
[Abstract] [Full Text]


Home page
ChestHome page
T. C. Y. Tsao, J.-h. Hong, L.-F. Li, M.-J. Hsieh, S.-K. Liao, and K. S. S. Chang
Imbalances Between Tumor Necrosis Factor-{alpha} and Its Soluble Receptor Forms, and Interleukin-1{beta} and Interleukin-1 Receptor Antagonist in BAL Fluid of Cavitary Pulmonary Tuberculosis*
Chest, January 1, 2000; 117(1): 103 - 109.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
J. HIRSCH, A. ELSSNER, G. MAZUR, K. L. MAIER, I. BITTMANN, J. BEHR, M. SCHWAIBLMAIR, H. REICHENSPURNER, H. FÜRST, J. BRIEGEL, et al.
Bronchiolitis Obliterans Syndrome after (Heart-)Lung Transplantation . Impaired Antiprotease Defense and Increased Oxidant Activity
Am. J. Respir. Crit. Care Med., November 1, 1999; 160(5): 1640 - 1646.
[Abstract] [Full Text]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
J. T. Allen, C. A. Bloor, R. A. Knight, and M. A. Spiteri
Expression of Insulin-like Growth Factor Binding Proteins in Bronchoalveolar Lavage Fluid of Patients with Pulmonary Sarcoidosis
Am. J. Respir. Cell Mol. Biol., August 1, 1998; 19(2): 250 - 258.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1990 by the European Respiratory Society.